ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

All Content

Updated results of the ASSURE trial showed that adjuvant sunitinib or sorafenib did not improve disease-free survival among high-risk patients with renal cell carcinoma.

The FDA has recently released a statement identifying a new rare T-cell lymphoma caused by breast implant surgery.

ASCO has released a statement announcing its opposition to President Trump’s budget outline for FY2018, which would cut about $6 billion in funding to the National Institutes of Health.

A novel calculator can more easily identify which esophageal adenocarcinoma patients derive an overall survival benefit from neoadjuvant chemoradiation to help guide treatment choices.

This video examines research that found that certain genetic variations of both leukemia patients undergoing bone marrow transplant and their unrelated donors were associated with poor outcomes.

A 67-year-old man presents with gastric pain, and a biopsy is performed. What is your diagnosis?

No difference in time to recurrence, recurrence-free survival, or overall survival were noted for patients with rectal cancer who underwent one of three different preoperative radiotherapy regimens.

This video highlights some of the latest developments guiding precision medicine for lung cancer in clinical practice.

A study of the combination of radiation therapy and immune checkpoint inhibitors for the treatment of advanced lung cancer found a modest risk of side effects.

In this interview we discuss how quality-of-life information from patients with lung cancer can be used to help guide treatment and inform outcomes.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.